QI
CNMD icon

QS Investors’s CONMED CNMD Stock Holding History

QS Investors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800
Closed -$58K – 1249
2020
Q2 		$58K Hold
800
– – ﹤0.01% 1433
2020
Q1 		$46K Sell
800
-900
-53% -$83K ﹤0.01% 1416
2019
Q4 		$190K Sell
1,700
-1,500
-47% -$160K ﹤0.01% 1197
2019
Q3 		$308K Hold
3,200
– – ﹤0.01% 1084
2019
Q2 		$274K Buy
+3,200
New +$263K ﹤0.01% 1131

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

QS Investors's CNMD Position: Q3 2020 in Review

QS Investors sold out of CONMED (CNMD) in Q3 2020, closing a stake of 800 shares — an estimated $58K sold.

QS Investors first reported a position in CNMD in Q2 2019 and held it in 5 quarters. The position peaked at $308K in Q3 2019. 240 funds tracked by Wall St. Rank hold CNMD as of Q3 2020.

  • QS Investors reported no remaining CONMED position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 800 CONMED shares in Q3 2020, an estimated $58K.
  • QS Investors first reported a position in CONMED in Q2 2019 and held it in 5 quarters.
  • QS Investors's CONMED position peaked at $308K in Q3 2019.
  • 240 funds tracked by Wall St. Rank held CONMED as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.